The FDA previously designated the ADC as a breakthrough drug for relapsed or refractory extensive-stage small-cell lung ...
London: GSK plc has announced that the US Food and Drug Administration (USFDA) has granted Breakthrough Therapy Designation ...
GSK announced on Tuesday that its investigational antibody-drug conjugate GSK'227 has been granted breakthrough therapy ...